iRadimed Corporation (IRMD) News
Filter IRMD News Items
IRMD News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
IRMD News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest IRMD News From Around the Web
Below are the latest news stories about IRADIMED CORP that investors may wish to consider to help them evaluate IRMD as an investment opportunity.
IRADIMED CORPORATION Reports Preliminary Unaudited Record Fourth Quarter and Full-Year 2024 RevenuesReports preliminary fourth quarter 2024 revenue in the range of approximately $19.2 million to $19.4 millionReports preliminary full-year 2024 revenue in the range of approximately $73.1 million to $73.3 millionIradimed is scheduled to present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15th, 2025, at 5:15 p.m. PT WINTER SPRINGS, Fla., Jan. 10, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company” or “Iradimed”) (NASDAQ: IRMD), a leader in developing innovative Magneti |
Discovering Undiscovered Gems with Strong Potential This December 2024In the last week, the United States market has remained flat, yet it has achieved a remarkable 24% increase over the past year with earnings projected to grow by 15% annually in the coming years. In this dynamic environment, identifying stocks with strong potential involves seeking out companies that are not only resilient but also poised to capitalize on these favorable growth trends. |
IRADIMED CORPORATION to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceWINTER SPRINGS, Fla., Dec. 19, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leading provider of innovative magnetic resonance imaging (“MRI”) compatible medical devices and the only provider of a non-magnetic intravenous (“IV”) infusion pump system announced today that Roger Susi, Chief Executive Officer and Jack Glenn, Chief Financial Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference. The Company presentation will take place on Wednesd |
Should You Investigate IRADIMED CORPORATION (NASDAQ:IRMD) At US$54.43?While IRADIMED CORPORATION ( NASDAQ:IRMD ) might not have the largest market cap around , it led the NASDAQGM gainers... |
IRADIMED CORPORATION on Forbes’ List of America’s Most Successful Small-Cap Companies for 2025WINTER SPRINGS, Fla., Dec. 10, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), today announced it has been ranked 24th on Forbes’ list of America’s Most Successful Small-Cap Companies 2025. Iradimed is a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only provider of a non-magnetic intravenous (“IV”) infusion pump system and non-magnetic patient vital signs monitoring systems that are designed for use during MRI pr |
Three Undiscovered Gems in the US Market to Enhance Your PortfolioOver the last 7 days, the United States market has remained flat, yet it has experienced a significant rise of 31% over the past 12 months with earnings forecasted to grow by 15% annually. In such a dynamic environment, discovering lesser-known stocks with strong potential can be key to enhancing your portfolio and capitalizing on emerging opportunities. |
Is There An Opportunity With IRADIMED CORPORATION's (NASDAQ:IRMD) 47% Undervaluation?Key Insights The projected fair value for IRADIMED is US$100 based on 2 Stage Free Cash Flow to Equity IRADIMED's... |
IRADIMED CORPORATION (NASDAQ:IRMD) Passed Our Checks, And It's About To Pay A US$0.15 DividendIRADIMED CORPORATION ( NASDAQ:IRMD ) stock is about to trade ex-dividend in four days. The ex-dividend date is one... |
IRADIMED CORPORATION Named to Fortune’s 100 Fastest Growing Companies List for 2024WINTER SPRINGS, Fla., Nov. 04, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) was recently named one of Fortune’s 100 Fastest Growing Companies for 2024. Iradimed is a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only provider of a non-magnetic intravenous (“IV”) infusion pump system, and non-magnetic patient vital signs monitoring systems that are designed for use during MRI procedures. “Being recognized by Fort |
Results: IRADIMED CORPORATION Exceeded Expectations And The Consensus Has Updated Its EstimatesIRADIMED CORPORATION ( NASDAQ:IRMD ) shareholders are probably feeling a little disappointed, since its shares fell... |